Paper38136231
Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer.
González-Rodríguez M and 12 others. Antioxidants (Basel), 2023. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. Papers, record 38136231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136231
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30781364 | (-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo. | Nutrients | 2019 | https://conductscience.org/library/papers/30781364 | PubMed |
| 2 | 31072015 | (-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31072015 | PubMed |
| 3 | 37760079 | Oleacein and Oleocanthal: Key Metabolites in the Stability of Extra Virgin Olive Oil. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37760079 | PubMed |
| 4 | 24829485 | Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. | Adv Nutr | 2014 | https://conductscience.org/library/papers/24829485 | PubMed |
| 5 | 30261513 | Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30261513 | PubMed |
| 6 | 31766503 | The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation. | Nutrients | 2019 | https://conductscience.org/library/papers/31766503 | PubMed |
| 7 | 27014505 | Does a Mediterranean-Type Diet Reduce Cancer Risk? | Curr Nutr Rep | 2016 | https://conductscience.org/library/papers/27014505 | PubMed |
| 8 | 23044226 | Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 chondrocytes. | Life Sci | 2012 | https://conductscience.org/library/papers/23044226 | PubMed |
| 9 | 29149823 | Olive Oil-related Anti-inflammatory Effects on Atherosclerosis: Potential Clinical Implications. | Endocr Metab Immune Disord Drug Targets | 2018 | https://conductscience.org/library/papers/29149823 | PubMed |
| 10 | 19621072 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621072 | PubMed |
| 11 | 27259268 | (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27259268 | PubMed |
| 12 | 32988794 | Adherence to the Mediterranean Diet and Overall Cancer Incidence: The Netherlands Cohort Study. | J Acad Nutr Diet | 2021 | https://conductscience.org/library/papers/32988794 | PubMed |
| 13 | 30360768 | Polyphenolic extract from extra virgin olive oil inhibits the inflammatory response in IL-1β-activated synovial fibroblasts. | Br J Nutr | 2019 | https://conductscience.org/library/papers/30360768 | PubMed |
| 14 | 29959992 | Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer. | Toxicol In Vitro | 2018 | https://conductscience.org/library/papers/29959992 | PubMed |
| 15 | 27266366 | Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells. | Nutr Cancer | 2016 | https://conductscience.org/library/papers/27266366 | PubMed |
| 16 | 27258622 | Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27258622 | PubMed |
| 17 | 31394181 | Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities. | Int J Pharm | 2019 | https://conductscience.org/library/papers/31394181 | PubMed |
| 18 | 27783083 | Extra virgin olive oil: a key functional food for prevention of immune-inflammatory diseases. | Food Funct | 2016 | https://conductscience.org/library/papers/27783083 | PubMed |
| 19 | 19662776 | Multiple sclerosis and cancers in Croatia--a possible protective role of the "Mediterranean diet". | Coll Antropol | 2009 | https://conductscience.org/library/papers/19662776 | PubMed |
| 20 | 27762153 | Olive polyphenols: new promising agents to combat aging-associated neurodegeneration. | Expert Rev Neurother | 2017 | https://conductscience.org/library/papers/27762153 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738930 | Time-Dependent Multimechanistic Antitumor Effects of Olive Oil Phenolics in a Triple-Negative Breast Cancer Mouse Model. | Nutrients | 2026 | https://conductscience.org/library/papers/42738930 | PubMed |
| 42588039 | Extra Virgin Olive Oil: Molecular Mechanisms, Bioavailability Challenges, and Therapeutic Perspectives. | Nutrients | 2026 | https://conductscience.org/library/papers/42588039 | PubMed |
| 42459801 | Cold pressed oils: a systematic review on physicochemical properties, nutritional composition and pharmacological activities. | Front Nutr | 2026 | https://conductscience.org/library/papers/42459801 | PubMed |
| 42121450 | The Influence of Different Ultrasonication Parameters on Physicochemical Properties and Secoiridoid Compositions of Olive Extracts: A Mathematical Approach Using Artificial Neural Network (ANN) and Response Surface Methodology (RSM). | Foods | 2026 | https://conductscience.org/library/papers/42121450 | PubMed |
| 42037524 | Exploring the Nutraceutical Potential of Extra Virgin Olive Oils From Sicilian Well-Known and Lesser-Known Cultivars. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42037524 | PubMed |
| 41883417 | Association between triglyceride-glucose index-a body shape index and atherosclerotic cardiovascular disease, and the modification effect of dietary patterns. | Front Nutr | 2026 | https://conductscience.org/library/papers/41883417 | PubMed |
| 41596120 | Autofluorescence Profiling of Virgin Olive Oil: Impact of Rosemary and Basil Flavoring During Storage. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41596120 | PubMed |
| 41479097 | Polyphenols from Olive Oil: A Promising Therapeutic Approach for Neurodegenerative Diseases. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41479097 | PubMed |
| 41156614 | In Vitro Inhibition of Cryptosporidium parvum Infection by the Olive Oil Component Oleocanthal. | Pathogens | 2025 | https://conductscience.org/library/papers/41156614 | PubMed |
| 40888233 | Effect of Extra Virgin Olive Oil High in Bioactive Compounds on Atherosclerosis in Apoe-Deficient Mice. | Mol Nutr Food Res | 2025 | https://conductscience.org/library/papers/40888233 | PubMed |
| 40732959 | Extra Virgin Olive Oil (EVOO) Components: Interaction with Pro-Inflammatory Cytokines Focusing on Cancer and Skeletal Muscle Biology. | Nutrients | 2025 | https://conductscience.org/library/papers/40732959 | PubMed |
| 40564985 | Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40564985 | PubMed |
| 40516087 | Interaction Between Attributes and Familiarity in Consumer Preferences for Olive Oil: Using Consumers' Residence as a Proxy for Familiarity. | J Food Sci | 2025 | https://conductscience.org/library/papers/40516087 | PubMed |
| 40243559 | Selective Modulation of PAR-2-Driven Inflammatory Pathways by Oleocanthal: Attenuation of TNF-α and Calcium Dysregulation in Colorectal Cancer Models. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243559 | PubMed |
| 40005119 | New Insights in Natural Bioactive Compounds for Periodontal Disease: Advanced Molecular Mechanisms and Therapeutic Potential. | Molecules | 2025 | https://conductscience.org/library/papers/40005119 | PubMed |
| 39940428 | Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus. | Nutrients | 2025 | https://conductscience.org/library/papers/39940428 | PubMed |
| 39795195 | The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway. | Molecules | 2025 | https://conductscience.org/library/papers/39795195 | PubMed |
| 39758311 | Impact of a glutamine-enriched peptide formula on gastrointestinal toxicity and on the interruption of oncologic treatment in patients with adenocarcinoma of the rectum. | Front Nutr | 2024 | https://conductscience.org/library/papers/39758311 | PubMed |
| 39696776 | The role of olive oil and its constituents in mental health: a scoping review. | Br J Nutr | 2024 | https://conductscience.org/library/papers/39696776 | PubMed |
| 39691690 | Effect of oleocanthal-rich olive oil on postprandial oxidative stress markers of patients with type 2 diabetes mellitus. | Food Nutr Res | 2024 | https://conductscience.org/library/papers/39691690 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136231
GET https://conductscience.org/api/papers/v1/38136231/references?page=2